- JP-listed companies
- CHUGAI PHARMACEUTICAL CO., LTD.
- Income statement
CHUGAI PHARMACEUTICAL CO., LTD.【JP:4519】Income statement
Market cap
¥14.14T
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 373,516 | 391,220 | 426,003 | 461,109 | 498,839 | 491,780 | 534,199 | 579,787 | 686,184 | 786,946 | 999,759 | 1,259,946 | 1,111,367 | 1,170,611 |
| Cost of revenue | - | - | - | 214,484 | 240,390 | 244,836 | 255,245 | 264,430 | 266,071 | 273,465 | 338,147 | 476,251 | 413,306 | 339,409 |
| Gross profit | - | - | - | 237,291 | 249,370 | 242,066 | 270,807 | 307,310 | 420,113 | 513,481 | 661,612 | 783,695 | 698,061 | 831,201 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 71,910 | 72,850 | 69,048 | 86,583 | 109,566 | 210,597 | 301,230 | 421,897 | 533,309 | 439,174 | 542,002 |
| Operating expenses | - | - | - | 165,381 | 176,520 | 173,018 | 184,224 | 197,744 | 211,205 | 222,217 | 247,979 | 260,242 | 112,580 | 110,098 |
| Income before tax | 63,585 | 75,406 | 77,764 | 76,164 | 87,276 | 74,448 | 97,031 | 121,449 | 207,893 | 298,188 | 419,385 | 531,166 | 443,821 | 543,034 |
| Provision for income taxes | - | - | - | 24,358 | 23,235 | 19,953 | 21,062 | 26,058 | 50,333 | 83,455 | 116,390 | 156,737 | 118,349 | 155,717 |
| Net income | 35,234 | 48,205 | 50,895 | 50,980 | 61,125 | 53,592 | 72,713 | 92,488 | 157,560 | 214,733 | 302,995 | 374,429 | 325,472 | 387,317 |
| Earnings per share | 64.75 | 88.58 | 93.47 | 93.53 | 112 | 98.12 | 133.04 | 169.08 | 287.84 | 130.66 | 184.29 | 227.64 | 197.83 | 235.39 |
| Diluted EPS | 64.73 | 88.54 | 92.84 | 93.52 | 102.79 | 93.07 | 127.37 | 157.92 | 287.43 | 130.53 | 184.17 | 227.57 | 197.8 | 235.36 |
| Dividend payout ratio (%) | - | - | - | - | - | - | - | - | - | |||||
| Dividend per share | 40 | 40 | 45 | 48 | 58 | 52 | 62 | 86 | 140 | 55 | 76 | 78 | 80 | 98 |